Inventor · disambiguated record
Jan Weiler
Also filed as: WEILER JAN
15 granted patents·18 pending applications·96 citations·filing 2001–2024
91Inventor score
Top patents by PatentIndex Score
33 records- 0194US10287354B2Regulatable chimeric antigen receptorNOVARTIS AG·Filed 2014·Granted May 14, 2019·29 cites·63 claims
- 0290US10240153B2Organic compositions to treat APOC3-related diseasesARROWHEAD PHARMACEUTICALS INC·Filed 2017·Granted Mar 26, 2019·7 cites·17 claims
- 0390US8097716B2Interfering RNA duplex having blunt-ends and 3′-modificationsWEILER JAN·Filed 2008·Granted Jan 17, 2012·41 cites·10 claims
- 0485US9988627B2Formats for organic compounds for use in RNA interferenceBARYZA JEREMY LEE·Filed 2014·Granted Jun 5, 2018·9 cites·21 claims
- 0583US11578130B2Regulatable chimeric antigen receptorNOVARTIS AG·Filed 2018·Granted Feb 14, 2023·1 cites·30 claims
- 0683US2025270555A1Organic compositions to treat beta-catenin-related diseasesARROWHEAD PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0777US11066667B2Organic compositions to treat APOC3-related diseasesARROWHEAD PHARMACEUTICALS INC·Filed 2019·Granted Jul 20, 2021·1 cites·18 claims
- 0875US9868949B2Organic compositions to treat EPAS1-related diseasesARROWHEAD RES CORPORATION·Filed 2014·Granted Jan 16, 2018·5 cites·20 claims
- 0973US10538765B2Organic compositions to treat EPAS1-related diseasesARROWHEAD PHARMACEUTICALS INC·Filed 2017·Granted Jan 21, 2020·1 cites·19 claims
- 1072US2023026049A1Regulatable chimeric antigen receptorNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1171US11473083B2Compositions and methods for decreasing tau expressionNOVARTIS AG·Filed 2016·Granted Oct 18, 2022·1 cites·10 claims
- 1267US11261444B2Organic compositions to treat EPAS1-related diseasesARROWHEAD PHARMACEUTICALS INC·Filed 2020·Granted Mar 1, 2022·0 cites·17 claims
- 1365US10519446B2Organic compounds to treat hepatitis B virusNOVARTIS AG·Filed 2014·Granted Dec 31, 2019·1 cites·14 claims
- 1462US2022411796A1Compositions and methods for decreasing tau expressionNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1561US11008570B23′ end caps for RNAi agents for use in RNA interferenceNOVARTIS AG·Filed 2019·Granted May 18, 2021·0 cites·20 claims
- 1657US2010280094A1Compositions and methods to treat muscular & cardiovascular disordersNOVARTIS AG·Filed 2007·Application pending·0 cites
- 1755US10227588B23′end caps for RNAi agents for use in RNA interferenceNOVARTIS AG·Filed 2014·Granted Mar 12, 2019·0 cites·18 claims
- 1855US2018282728A1Organic compositions to treat beta-catenin-related diseasesARROWHEAD PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1954US2007203084A1Interfering Rna Duplex Having Blunt-Ends And 3'-ModificationsWEILER JAN·Filed 2004·Application pending·0 cites
- 2052US10329563B2Organic compositions to treat HSF1-related diseasesARROWHEAD PHARMACEUTICALS INC·Filed 2017·Granted Jun 25, 2019·0 cites·13 claims
- 2152US10023862B2Organic compositions to treat beta-catenin-related diseasesHUESKEN DIETER·Filed 2013·Granted Jul 17, 2018·0 cites·9 claims
- 2252US2019323008A1Organic compositions to treat hsf1-related diseasesARROWHEAD PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2349US2015238515A1Organic compositions to treat kras-related diseasesARROWHEAD RES CORP·Filed 2013·Application pending·0 cites
- 2449US2012114744A1Compositions and methods to treat muscular & cardiovascular disordersBEUVINK IWAN·Filed 2012·Application pending·0 cites
- 2547US2012041052A1Compositions and Methods to Treat Muscular & Cardiovascular DisordersBEUVINK IWAN·Filed 2011·Application pending·0 cites
- 2647US2006135453A1Down-regulation of target-gene with pei/single-stranded oligoribonucleotide complexesBOLOGNA JEAN-CHARLES·Filed 2004·Application pending·0 cites
- 2745US2018153919A1Organic compositions to treat kras-related diseasesARROWHEAD PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2845US2008045417A1Oligonucleotide MicroarrayWEILER JAN·Filed 2004·Application pending·0 cites
- 2944US2006128644A1Use of mob-5 in painBARCLAY JANE·Filed 2004·Application pending·0 cites
- 3044US2003124523A1Organic compoundsFiled 2001·Application pending·0 cites
- 3143US2016032284A1Organic compositions to treat hsf1-related diseasesCHEN JINYUN·Filed 2012·Application pending·0 cites
- 3243US2007282098A1Process for combining parallel oligonucleotide synthesisWEILER JAN·Filed 2007·Application pending·0 cites
- 3337US2021180053A1Synthetic rnas and methods of useNOVARTIS AG·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jan Weiler files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →